# SweetBio, Inc.

> SweetBio, Inc. is a Memphis-based medical device company that bioengineers manuka honey into solid, easy-to-apply wound dressings. Its flagship product, APIS, combines a collagen derivative, UMF-certified manuka honey, and hydroxyapatite into a trimmable sheet that is FDA-cleared and Medicare-covered for managing chronic and acute wounds, including diabetic foot ulcers. Founded in 2015 by sibling co-founders Kayla Rodriguez Graff and Dr. Isaac Rodriguez, the woman-led, Latinx-founded company aims to make advanced wound care accessible and affordable - taking a remedy as old as the ancient Egyptians and delivering it in a modern, standardized form.

- **Founded:** 2015
- **Headquarters:** Memphis, Tennessee, United States
- **Founders:** Kayla Rodriguez Graff (Co-founder & CEO), Dr. Isaac Rodriguez (Co-founder & Chief Science Officer)
- **Team size:** ~11 employees
- **Products:** APIS, VERIS, MXTECH biomaterial platform
- **Notable:** APIS received FDA 510(k) clearance (K182725) on May 31, 2019, Memphis Magazine 2016 Innovation Award winner, Graduate of the ZeroTo510 medical device accelerator (2015); reportedly declined a Y Combinator invitation to build in Memphis

## Products & services

- **APIS** — The flagship bioengineered wound product: a solid, trimmable sheet combining a collagen derivative, UMF-certified manuka honey, and hydroxyapatite. FDA-cleared and Medicare-covered for the management of chronic and acute wounds, including diabetic foot ulcers and surgical wounds. Contains no human tissue, which simplifies regulation and billing. Named for Apis mellifera, the honeybee.
- **VERIS** — A daily wound dressing positioned as the everyday complement to APIS, Medicare-reimbursed under HCPCS A6021, designed for simple, cost-effective wound management.
- **MXTECH biomaterial platform** — The underlying bioengineered biomaterial technology - a synthesized sheet of collagen derivative, manuka honey, and hydroxyapatite - that provides structural support, regulates inflammation, reduces bacterial burden, and encourages granulation and angiogenesis.

## Achievements

- APIS received FDA 510(k) clearance (K182725) on May 31, 2019
- Memphis Magazine 2016 Innovation Award winner
- Graduate of the ZeroTo510 medical device accelerator (2015); reportedly declined a Y Combinator invitation to build in Memphis
- Selected for the Springboard Enterprises Health Innovation Hub (2019)
- Finalist in Steve Case's 2018 Rise of the Rest tour
- Co-founder Dr. Isaac Rodriguez named to Memphis Top 40 Under 40 (2015); keynoted NASA Langley's 2017 Hispanic Heritage Month
- Featured across Forbes, Inc., 60 Minutes, and a national Prudential campaign
- Achieved Medicare coverage for its wound products

## Latest updates

- **2019-05** — APIS received FDA 510(k) clearance and SweetBio solidified its pivot to the wound care market.
- **2021-02** — Closed its most recent reported funding; connected to VamosVentures capital linked to Apple's Racial Equity and Justice Initiative.
- **2023-06** — Founders featured in a YouTube interview discussing SweetBio and its Wound Care Kits.
- **2024-01** — CEO Kayla Rodriguez Graff presented at the LSI USA '24 life sciences conference.
- **2025-11** — Kayla Rodriguez Graff appeared on the Hispanic MPR podcast discussing modern wound care.
- **2026-03** — Announced commercial launch of APIS through exclusive distribution partner Resolve Medical.
- **2026-04** — Announced a strategic national distribution partnership with BioLab Holdings, Inc.

## Links

- Website: https://sweetbio.com
- LinkedIn: https://www.linkedin.com/company/sweetbio-inc-
- Twitter/X: https://twitter.com/sweetbioco
- YouTube: https://www.youtube.com/watch?v=zEMzi8XaBk0
- Instagram: https://www.instagram.com/sweetbio.inc
- Facebook: https://www.facebook.com/sweetbioco

---

Profile page: https://yespress.io/sweetbio-inc
Published by YesPress — https://yespress.io
Last updated: 2026-07-02